The Cost of Chronic Disease and the Future of Treatment

The Cost of Chronic Disease and the Future of Treatment



The increasing prevalence of chronic diseases—including diabetes, heart disease, and multiple types of cancer—is a global trend that has seen a sharp rise in the MENA region. Experts will examine risk factors, discuss future trends, and identify responses to reduce the regional chronic disease burden. Discussion will focus on the role that public education, lifestyle behaviors, science, and technology—such as genomic data and gene therapy—can play in terms of preventing obesity and reducing the cost of chronic disease.

Custom Author Text


Hugh Waters

Director, Health Economics Research, Milken Institute



Hawaa Althahak Almansoori

Consultant Endocrinologist and Deputy Medical Director, Imperial College London Diabetes Centre Abu Dhabi


Sumit Jamuar, Chairman and CEO, Global Gene Corp


Nancy Knight

Director, Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention (CDC)


Freda Lewis-Hall

Executive Vice President and Chief Patient Officer, Pfizer